227 related articles for article (PubMed ID: 35590037)
21. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE; van de Kerkhof P; Gudjonsson JE; de la Cruz C; Barker J; Morita A; Romiti R; Affandi AM; Asawanonda P; Burden AD; Gonzalez C; Marrakchi S; Mowla MR; Okubo Y; Oon HH; Terui T; Tsai TF; Callis-Duffin K; Fujita H; Jo SJ; Merola J; Mrowietz U; Puig L; Thaçi D; Velásquez M; Augustine M; El Sayed M; Navarini AA; Pink A; Prinz J; Turki H; Magalhães R; Capon F; Bachelez H;
JAMA Dermatol; 2024 May; ():. PubMed ID: 38691347
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares.
Choon SE; Lebwohl MG; Turki H; Zheng M; Burden AD; Li L; Quaresma M; Thoma C; Bachelez H
Dermatology; 2023; 239(3):345-354. PubMed ID: 36796336
[TBL] [Abstract][Full Text] [Related]
23. Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study.
Navarini AA; Prinz JC; Morita A; Tsai TF; Viguier MA; Li L; Thoma C; Sivalingam M; Lebwohl MG
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):730-736. PubMed ID: 36527385
[TBL] [Abstract][Full Text] [Related]
24. Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists.
Strober B; Kotowsky N; Medeiros R; Mackey RH; Harrold LR; Valdecantos WC; Flack M; Golembesky AK; Lebwohl M
Dermatol Ther (Heidelb); 2021 Apr; 11(2):529-541. PubMed ID: 33638115
[TBL] [Abstract][Full Text] [Related]
25. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
[TBL] [Abstract][Full Text] [Related]
26. Clinical Course and Characteristics of Generalized Pustular Psoriasis.
Choon SE; Navarini AA; Pinter A
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and course of generalized pustular psoriasis in Korea.
Jin H; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim H; Kim BS
J Dermatol; 2015 Jul; 42(7):674-8. PubMed ID: 25819215
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus.
Prignano F; Atzori L; Bellinato F; Damiani G; Galeone C; Mariani P; Potenza C; Scopinaro A; Piaserico S; Fabbrocini G;
Dermatology; 2024; 240(3):414-424. PubMed ID: 38493762
[TBL] [Abstract][Full Text] [Related]
29. Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI).
Burden AD; Bissonnette R; Lebwohl MG; Gloede T; Anatchkova M; Budhiarso I; Hu N; Thoma C; Skalicky AM; Bachelez H
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1327-1335. PubMed ID: 36854864
[TBL] [Abstract][Full Text] [Related]
30. Generalized pustular psoriasis in Brazil: A public claims database study.
Duarte GV; Esteves de Carvalho AV; Romiti R; Gaspar A; Gomes de Melo T; Soares CP; Aguirre AR
JAAD Int; 2022 Mar; 6():61-67. PubMed ID: 35059660
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of Generalized Pustular Psoriasis.
Fujita H; Gooderham M; Romiti R
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):31-38. PubMed ID: 35061226
[TBL] [Abstract][Full Text] [Related]
32. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.
Morita A; Kotowsky N; Gao R; Shimizu R; Okubo Y
J Dermatol; 2021 Oct; 48(10):1463-1473. PubMed ID: 34212422
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
Song EJ; Liu C
Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
Okubo Y; Umezawa Y; Sakurai S; Hoshii N; Nakagawa H
Dermatol Ther (Heidelb); 2022 Jun; 12(6):1397-1415. PubMed ID: 35622315
[TBL] [Abstract][Full Text] [Related]
35. The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale.
Mannix S; Edson-Heredia E; Paller AS; Yosipovitch G; Burge R; Kleinman L
Pediatr Dermatol; 2021 Mar; 38(2):405-412. PubMed ID: 33336430
[TBL] [Abstract][Full Text] [Related]
36. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
37. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
38. Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial.
Warren RB; Reich A; Kaszuba A; Placek W; Griffiths CEM; Zhou J; Randazzo B; Lizzul P; Gudjonsson JE
Br J Dermatol; 2023 Jul; 189(2):161-169. PubMed ID: 37120722
[TBL] [Abstract][Full Text] [Related]
39. Generalized pustular psoriasis: current management status and unmet medical needs in Japan.
Komine M; Morita A
Expert Rev Clin Immunol; 2021 Sep; 17(9):1015-1027. PubMed ID: 34402355
[TBL] [Abstract][Full Text] [Related]
40. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
Boehner A; Navarini AA; Eyerich K
Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
